ARCHIVES

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

This article is from The Cancer Letter archive.

Vol. 24 No. 07 | February 20, 1998

Download PDF Visit The Full Archive

Related Articles

Peter Jones begins term as AACR president-elect. New directors elected.

April 2, 2004

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

December 14, 2007

Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer

October 25, 2021

Lombardi Center Officials Say New Partnership To Provide For Expansion In Services, Patients.

February 23, 2001

DRG Regulation Opponents May Have Powerful New Ally

November 25, 1983

Dexamethasone Improved Survival Of Leukemia

November 26, 2004